Galderma Group AG (GALD) Raises 2026 Sales Outlook After 9M Sales Up 25.1% CC

Galderma raised its 2026 net sales growth guidance to 22.5—23.5% at constant currency after reporting 9M sales of $4.765B, up 25.1% CC. Core EBITDA margin guidance remains ~26% CC.Material DetailsContext by AI AnalystThis is a mid-cycle confirmation of accelerating growth and confidence, with guida…